Cargando…
Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis
BACKGROUND: Focal segmental glomerulosclerosis (FSGS) is a major cause of end-stage renal disease. Recent studies have proposed that plasma soluble urokinase receptor (suPAR) might be a causative circulating factor but this proposal has caused controversy. This study aimed to measure urinary suPAR l...
Autores principales: | Huang, Jing, Liu, Gang, Zhang, Yi-miao, Cui, Zhao, Wang, Fang, Liu, Xiao-jing, Chu, Rong, Zhao, Ming-hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064821/ https://www.ncbi.nlm.nih.gov/pubmed/24884842 http://dx.doi.org/10.1186/1741-7015-12-81 |
Ejemplares similares
-
Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View
por: Kronbichler, Andreas, et al.
Publicado: (2016) -
Serum soluble urokinase type plasminogen activated receptor and focal segmental glomerulosclerosis: a systematic review and meta-analysis
por: Shuai, Tiankui, et al.
Publicado: (2019) -
Complement activation profile of patients with primary focal segmental glomerulosclerosis
por: Huang, Jing, et al.
Publicado: (2020) -
Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin
por: Hladunewich, Michelle A., et al.
Publicado: (2021) -
Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China
por: Guo, Shui-Ming, et al.
Publicado: (2015)